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Abstract
Objectives: Respiratory Syncytial Virus (RSV) is the leading cause of hospitalization for lower
respiratory tract infections (LRTI) in young children worldwide.
We evaluate the epidemiological and clinical patterns of RSV infection in infants hospitalized for
LRTI in in Palermo, South Italy, Sicily.
Methods: We collected the demographic details of infants hospitalized to G. Di Cristina Children's
Hospital in Palermo for LRTI between November 2005 and May 2006. We also included all cases
occurred in newborns hospitalized in the Neonatal Intensive Care Unit (NICU) Of Palermo.
Results: During the studied period, 335/705 hospitalized infants for LRTI were enrolled in the
study. The trend of hospitalization started in late winter and lasting until May 2006 with an epidemic
peak in spring. 178/335 infants tested for viral infection showed RSV disease. Three cases occurred
in preterm newborns hospitalized from birth in NICU. The likelihood to be RSV+, rather than RSV
negative (RSV-) was higher for infants < 6 months and lower for infants with history of breast
feeding (P < 0.05). RSV infection was associated with a higher likelihood to be admitted to intensive
care unit and to a longer hospitalization and oxygen therapy.
Conclusion: The study shows that, in Sicily, RSV is an important cause of LRTI in infants. The
seasonal distribution shows that both LRTI and RSV infections peak in late spring, in contrast to
Northern Italy. Our data could help to define the regional appropriate start of prophylactic
interventions.
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Introduction
Almost all children are infected by Respiratory Syncytial
Virus (RSV) at least once by 2 years of age, and approxi-
mately 1–2% of infants will require hospitalization for
RSV-associated Lower Respiratory Tract Infections (LRTI)
[1-3].
Infection rates vary from 50–70% during the first year of
life, to 100% during the second-third year of age. Immu-
nity, however, is not complete, and reinfection is com-
mon [1-4].
Evidence of RSV infection has been found in every geo-
graphic area studied. In countries with a temperate cli-
mate, outbreaks generally occur during the autumn and
last until spring, with the number of infections peaking in
January-March. In tropical areas, epidemics generally
coincide with the rainy season [5-7].
Although palivizumab can reduce the rate of hospitaliza-
tion due to RSV-LRTI, it is costly to administer, therefore
local data need to be evaluated to formulate guidelines
and justify its use, especially in countries with economic
difficulties [8].
In Italy, RSV outbreaks begin in the late winter and last
until spring, reaching a peak in March.
Recent climate changes have influenced the regional trend
of the country, altering the start and peak of the RSV epi-
demic season [9,10].
Objective
the Authors conducted this study to evaluate the epidemi-
ological and clinical patterns of RSV infection in infants
hospitalized for LRTI in in Palermo, South Italy, Sicily.
Methods
Patients
A prospective surveillance study was performed from
October 1, 2005 to April 30, 2006. The study population
consisted of children admitted to the "G. Di Cristina",
Children Hospital of Palermo.
Consent for enrolment was sought from parents by study
personnel. All children less than 2 years of age who were
hospitalized with symptoms suggesting LRTI were
enrolled in the study. LRTI were categorized on the basis
of clinical and roentgenographic findings, according to
the criteria proposed by Ruuskanen and Ogra [11]. The
disease was diagnosed: a) as wheezy bronchitis, when an
acute illness characterized by cough, rhonchi, and expira-
tory wheezing was detected; b) as bronchiolitis, when
wheezing dyspnea, tachypnea and CXR hyperinflation of
the lung with or without areas of collapse were present; c)
as pneumonia when radiographic findings of lung paren-
chymal involvement, with interstitial-alveolar infiltrates
and/or consolidation, were found. The radiologist and the
clinicians allocating patients to these categories were
blinded as to RSV status.
Demographical, clinical and microbiological data were
prospectively collected and entered into an Access Data-
base (Microsoft). The following parameters were
recorded: demographic characteristics, breast-feeding, his-
tory of underlying diseases, history of admissions for res-
piratory problems, start and duration of symptoms, need
for intensive care, oxygen supplementation, results of
microbiology tests and chest radiograph.
We also evaluated the incidence of LRTI in all newborns hos-
pitalized in the N.I.C.U. of the 'Dipartimento Materno Infan-
tile-IMI' and the 'V. Cervello' Hospital in Palermo during the
same period. Informed consent was obtained from a parent
or guardian. The study was approved by the Ethics Commit-
tee of the ARNAS Hospital of Palermo, Italy.
Oximetry
Oxygen saturation (SaO2) and pulse rate were determined
upon admission and then daily, using a portable Nellcor
oximeter (Nellcor, Inc., Hayward, CA). Data were always
collected for at least 5 min (except for longer periods of
observation when measurements were not stable or not
considered reproducible), with the child awake and quiet
in room air and, when needed, in oxygen. Oxygen was
administered when SaO2 was <90% and amounts of oxy-
gen supplementation were recorded.
Admission in Intensive Care Unit (ICU) was decided
when the cardio-respiratory or the general conditions of
the patients required intensive care.
Virologic Studies
Nasopharyngeal swabs and throat specimens were col-
lected at the time of LRTI and tested for a panel of respira-
tory viruses by immunofluorescent test (PathoDx®
Respiratory Virus Panel Kit, Immunofluorescent test for 7
respiratory viruses: influenza A; influenza B; adenovirus;
parainfluenza 1, 2, 3; and RSV) in shell vial pre-CPE
assays, and conventional tube culture confirmation (CE,
Remel, Lenexa, KS 66215. USA), or for RSV alone by enzy-
matic diagnostic test (Now® RSV Test, Binax) according to
medical request-record.
Statistical analysis
Analysis was based on comparison of demographic data
between RSV + and RSV - infants. Between groups com-
parison was performed by means of chi-square test for cat-
egorical variables and by Student's t-test for continuous
variables collected in the study.Italian Journal of Pediatrics 2009, 35:11 http://www.ijponline.net/content/35/1/11
Page 3 of 6
(page number not for citation purposes)
Data were processed with a SPSS-pc statistical program. A
significance level of p < 0.05 was used throughout the
study.
Results
Of the 1219 children referred to the Emergency Unit of
the 'G. Di Cristina' Children's Hospital between Novem-
ber 2005 and May 2006, 705 (58%) were hospitalized
with suspected LRTI. The trend of LRTI hospitalization
started in November 2005, lasting until May 2006 with an
epidemic peak in March (figure 1). Of these 705 children,
n°35 were over 2 years old and n°25 had a history of two
or more previous hospitalizations and were carried out
from the study.
Of the remaining 645 infants, only 335 showed viral
investigation and were enrolled in the study.
The retrospective interview of the pediatricians on because
the viral investigation did not perform in the excluded
patients has showed that in 60% of the cases the patients
have been hospitalized in the weekend when viral analy-
sis was not routinely available, in 10% of the cases the
infants were early tested, in 3% of the cases the parents
have refused the investigation and in the remaining 27%
of cases the clinical, instrumental and epidemiological
investigations were considered suitable for the manage-
ment of LRTI. The percentage of exclusion showed an
equally distribution with the trend of hospitalization.
RSV was identified in 178/335 patients (53%), parainflu-
enza type 3 virus in 14, influenza A virus in 10 and aden-
ovirus in 2 cases. No combined virus infection was
observed. The epidemic peak of the LRTI occurred in
March, with a prevalence of RSV positivity of 63% raising
up to 80% in April, while no RSV positivity was seen in
October, November or December (figure 1).
The characteristic of 335 studied infants are shown in
table 1.
Independently from the RSV positivity, when evaluating
the age distribution, 132 (39%) of them were less than 3
months old and 220 (65%) were less than 6 months old.
Four (1%) infants were born before 32 weeks gestation,
16 (5%) were born between 33–35 weeks and the remain-
ing 315 patients (94%) were born after the 36th week. All
infants born before 32 weeks gestation were RSV-negative
and received palivizumab prophylaxis. None of the RSV
positive children received it. The distribution of gesta-
tional age (GA) showed that in our study population it
was <36 weeks in 6% of the subjects versus 4.0% in gen-
eral population [12,13].
Evaluating the distribution of birth weights, 4 infants
weighed under 1.500 g, 10 between 1.500–2.000 g, and
30 between 2000 and 2.500 g and the remaining 291
infants over 2.500 at birth.
187 of the 335 children (55,8%) were breast-fed for more
than 3 months.
Of the 335 enrolled children, 224 (67%) had diagnosis of
bronchiolitis, 35 (10%) had pneumonia, and 76 had
wheezy bronchitis (23%); respectively, 55% of the
patients with bronchiolitis, 16% of those with pneumo-
nia, and 29% of those with wheezy bronchitis showed
RSV infection.
One infant was affected by bronchopulmonary dysplasia
and 4 were affected by congenital cardiopathies.
During the studied period, three cases of RSV was identi-
fied in 3 preterm newborns (2 patients born at 28 weeks
gestation and 1 born in the 34th week) hospitalized from
birth in the neonatal intensive care unit (NICU). The RSV
respiratory diseases occurred before discharge when they
stayed in post-intensive area.
The age at time of admission was lower in RSV + rather
than in RSV-negative (RSV.) infants (p = 0.00). The likeli-
hood to be RSV+, rather than RSV-negative (RSV-), was
higher for infants < 6 months (p = 0.00) and lower in
infants with a history of breast-feeding (p = 0.02) (table
1). Other demographic and clinical characteristics were
evaluated but were not significantly different between
RSV+ and RSV- infants. Comparing severity of disease, a
tendency toward longer hospitalization and a longer oxy-
Seasonal trend of RSV infection in 335 enrolled infants Figure 1
Seasonal trend of RSV infection in 335 enrolled 
infants.Italian Journal of Pediatrics 2009, 35:11 http://www.ijponline.net/content/35/1/11
Page 4 of 6
(page number not for citation purposes)
gen therapy were detected in RSV+ infants when com-
pared with RSV-infants. (Table 1).
Furthermore, 10 RSV + infants were admitted to the Pedi-
atric Intensive Care Unit, on average for 11.3 days versus
no one infant in the RSV - patients. Only 1 patient
required assisted ventilation.
Discussion
Previous Italian surveillance study of acute respiratory
infections (ARI) in hospitalized infants had showed that
respiratory syncytial virus is the prevalent etiological
infectious agent [10]. The incidence of ARI tracked closely
with the RSV season, with the majority of infections occur-
ring from late winter through early spring.
RSV is a significant cause of morbidity leading to the hos-
pitalization of children in Palermo, particularly infants
under 2 years of age. The seasonal distribution of our
patients shows that RSV infections peak in late spring, in
contrast to Northern Italy. This pattern is similar to that
reported for tropical countries, where RSV infection also
occurs in the summer [5,14].
Efforts to prevent this infection are based on case manage-
ment, vaccination and the identification of risk factors.
Furthermore, in our report, we attempted to delineate
clinical pattern of RSV + hospitalized infants in a popula-
tion of south Italian children who experience extremely
high rates of hospitalization for LRTI. Our results show
that age at time of admission for LRTI was lower for
infants RSV + rather than RSV- (3 months versus 5
months) and the age 0–6 months increased the risk of RSV
hospitalization.
This is not surprising as a chronological age of 3 months
or less at the onset of the RSV season is a known risk factor
for severe RSV-induced LRTI [12-14]. In addition to the
small size of the conducting airways and incomplete
development of the lung structure, these infants are less
likely to have RSV-neutralizing maternal antibodies than
infants born after the peak of the RSV season [15]. Lung
growth and a more efficient immune response may
explain why a chronological age of > 6 months at the time
of hospitalization is associated with a lower likelihood of
being hospitalized for a LRTI due to RSV [14-16].
In our report, the study of LRTI population revalues the
protective effects of breast-feeding to RSV infection,
recently underlined by some studies.
It is not clear how breast-feeding reduces the risk of infec-
tion, although immunomodulatory constituents of
human milk seem to be protective [17].
Although recent immunological studies have tried to define
the mucosal and/or systemic mechanisms of protection
against respiratory infections during the early months of
life, more studies are required to identify which elements
modify the evolution of disease. Therefore the protective
role of breast-feeding must be carefully considered [17,18].
The statistical significant association between RSV infec-
tion and days of hospitalization and oxygen therapy con-
firms that this infection is cause of severity illness and that
prompt recognition of the diagnosis that include early
treatment with oxygen therapy helped to improve the
clinical state of the children [10,19-21]. In particular, hos-
pital stay greater than 5 days is considered one of relevant
data for score range of illness severity [21,22].






%Male (n = 214) 59 41 > 0.05
%Female (n = 121) 73 17 > 0.05
Age (months) 3 ± 1.4 5 ± 7.1 <0.05
%Age at time of hospitalization < 3 months (n = 132) 63 37 > 0.05
%Age at time of hospitalization < 6 months (n = 220) 59 41 <0.05
%Age at time of hospitalization > 6 months (n = 115) 43 57 > 0.05
Gestational age (weeks) 38 ± 1,7 38 ± 1,9 > 0.05
%Gestational age >36 weeks (n = 315) 45 55 > 0.05
Birth weight (gr.) 2986 ± 680 3023 ± 609 > 0.05
Birth weight group > 2500 g (n = 291) 44.3 55.7 > 0.05
Previous Hospitalization for LRTI (n = 97) 37 63 > 0.05
Breastfeeding (n = 187) 58 129 <0.05
Days of hospitalization 6.4 ± 3.5 5.6 ± 3.1 <0.05
Days of oxygen therapy (n = 235) 4.9 ± 3.3 4.1 ± 2.3 <0.05
Data are shown as percentage or means ± SD. The value of p refers to statistical significance of differences between the two populations;Italian Journal of Pediatrics 2009, 35:11 http://www.ijponline.net/content/35/1/11
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In accordance with this observation is the remark that in
our study all infants hospitalized in ICU were RSV+.
Nosocomial RSV infection were observed in NICU during
the studied season. These findings showed the relevant
role of viral infection to determine severe respiratory ill-
ness in hospitalized patients. Several studies conducted in
both community and healthcare settings have also dem-
onstrated that promoting hand-washing and good
hygiene practices to be adopted when coughing can help
reduce the transmission of acute respiratory infection
(ARI) [22]
Due to the low number of children with specific character-
istics, other risk factors such as presence of chronic lung
diseases or of congenital heart disease, congenital or
acquired immunodeficiency, haematological malignan-
cies, bone-marrow or organ transplants, and cystic fibrosis
were not analyzed.
There were two major limitations in our study. Firstly, no
clinical score was used in our hospital for children with
LRTI when the children were admitted to the Paediatric
Infectious Disease Unit and clinical data collected. Sec-
ondly, this study reports the results of only one tertiary
care medical center in Palermo. A comprehensive study
including local clinics, regional hospitals and medical
centers would provide more details of RSV infections in
Sicily.
In conclusion, RSV is the most important viral pathogen
in infants and children under the age of 2 years. The sea-
sonal trend of RSV infections in Palermo is "atypical",
with peaks in the late winter and spring.
Furthermore, the data provided by the study on the
expected onset and end of the RSV season indicates that
palivizumab prophylaxis start should be discussed keep-
ing in mind the substantial variability in community RSV
season timing.
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